Search - tctmd.com

Displaying 641 - 660 of 743

Sort: Relevancy | Date

Presentation SIF 2017

TAVR Durability: Recent Insights

Presenter: David L. Brown

March 11, 2017

Presentation SIF 2017

Novel Applications: Utilizing Impella to Support TAVR Patients

Presenter: Robert D. Riley

March 11, 2017

Presentation SIF 2017

Cardiologists "Need" the Surgeons to Optimize the Quality of Their Structural Heart Program

Presenter: Robert D. Riley

March 11, 2017

Presentation SIF 2017

Bicuspid Valve Disease

Presenter: Michael J. Reardon

March 11, 2017

Presentation SIF 2017

TAVR Will Be Default in Low Risk Patients

Presenter: David L. Brown

March 11, 2017

Presentation SIF 2017

Optimizing Program Efficiency

Presenter: Vinod H. Thourani

March 11, 2017

Presentation SIF 2017

Next Generation TAVR Devices with Case Examples

Presenter: David G. Rizik

March 11, 2017

Presentation SIF 2017

Coronary Disease and TAVR

Presenter: Robert J. Applegate

March 11, 2017

Presentation SIF 2017

Best Practices: Evolut R

Presenter: Ramon Quesada

March 11, 2017

Presentation SIF 2017

Valve-in-Valve: What You Need to Know

Presenter: Samir Kapadia

March 11, 2017

Presentation SIF 2017

Conduction Abnormalities Post TAVR

Presenter: William B. Bachinsky

March 11, 2017

Presentation SIF 2017

Best Practices: Sapien 3

Presenter: Samir Kapadia

March 11, 2017

Presentation SIF 2017

Bicuspid Aortic Valve Disease and TAVR

Presenter: Michael J. Reardon

March 11, 2017

Presentation SIF 2017

State of the Art 2017: How You Will Be Managing Aortic Stenosis in 2020?

Presenter: Vinod H. Thourani

March 11, 2017

News Conference News ACC 2017

ACC 2017: CVD Outcomes for Evolocumab, Intermediate-Risk TAVR, Coronary Physiology Tests, and More

Shelley Wood

March 10, 2017

Presentation SIF 2017

If at First It Doesn’t Succeed…

Presenter: Molly Szerlip

March 09, 2017

Presentation SIF 2017

While We Like Having Surgeons Around, We Wouldn’t Say We ‘Need’ Them…..

Presenter: David L. Brown

March 09, 2017

News Daily News

Edward ‘Ted’ Diethrich, Founder of the Arizona Heart Institute, Dies at 81

L.A. McKeown

March 01, 2017

Ticagrelor May Be Useful for Secondary Prevention After Stroke, TIA If Initial Event Is Related to Atherosclerosis

News Conference News ISC 2017

Ticagrelor May Be Useful After Stroke, TIA if Event Related to Atherosclerosis

Todd Neale

February 28, 2017

News Opinion Conversations in Cardiology

Conversations in Cardiology: For Fellows, How Much Structural Heart Disease Training Is Enough?

February 27, 2017

Advertisement

TAVR Durability: Recent Insights

Novel Applications: Utilizing Impella to Support TAVR Patients

Cardiologists "Need" the Surgeons to Optimize the Quality of Their Structural Heart Program

Bicuspid Valve Disease

TAVR Will Be Default in Low Risk Patients

Optimizing Program Efficiency

Next Generation TAVR Devices with Case Examples

Coronary Disease and TAVR

Best Practices: Evolut R

Valve-in-Valve: What You Need to Know

Conduction Abnormalities Post TAVR

Best Practices: Sapien 3

Bicuspid Aortic Valve Disease and TAVR

State of the Art 2017: How You Will Be Managing Aortic Stenosis in 2020?

ACC 2017: CVD Outcomes for Evolocumab, Intermediate-Risk TAVR, Coronary Physiology Tests, and More

If at First It Doesn’t Succeed…

While We Like Having Surgeons Around, We Wouldn’t Say We ‘Need’ Them…..

Edward ‘Ted’ Diethrich, Founder of the Arizona Heart Institute, Dies at 81

Ticagrelor May Be Useful After Stroke, TIA if Event Related to Atherosclerosis

Conversations in Cardiology: For Fellows, How Much Structural Heart Disease Training Is Enough?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content